Mammalian Expression: Enhance Research with Tailored Solutions & Insights

Looking for a reliable partner for mammalian expression? Look no further than Alpha Lifetech Incorporation. Our mammalian expression service offers high-quality Protein production in mammalian cells, allowing for the expression and purification of a wide range of proteins for various research and therapeutic applications, At Alpha Lifetech Incorporation, we understand the importance of robust and efficient mammalian expression systems in the production of recombinant proteins. Our team of experienced scientists is dedicated to providing customized solutions to meet your specific project requirements. We offer a comprehensive range of services, including cell line development, process optimization, and scale-up production

Hot Selling Product

ADT1005-Abciximab Biosimilar: (ITGA2B_ITGB3)- Research Grade

ALP64509-Recombinant Human Siglec-10 Protein, mFc Tag

ALP64519-Recombinant Human CD3E/CD3 Epsilon Protein, mFc Tag

ALP64546-Recombinant Human CD273/PD-L2/B7-DC Protein, His Tag, Avi Tag

ALP64560-Recombinant Human CD28 Protein, mFc Tag

Why Consider Mammalian Expression Your End-to-End Solution Products

In the ever-evolving landscape of biopharmaceutical development, the quest for high-quality reagents is paramount. At Alpha Lifetech Inc., we understand that the successful production of complex biomolecules, such as membrane proteins and monoclonal antibodies, hinges on choosing the right expression system. This is where mammalian expression technology shines as a comprehensive, end-to-end solution. By leveraging mammalian cell lines, we ensure authentic post-translational modifications, resulting in products that perform exceptionally in both research and therapeutic applications. Our team at Alpha Lifetech comprises seasoned scientists with a rich background in membrane protein production, Nanobody discovery, and monoclonal antibody development. With nearly 10,000 high-quality spot membrane protein reagents, cytokines, and drug target antibodies launched, we have positioned ourselves as a leading supplier in the industry. By prioritizing mammalian expression systems, we provide global procurement partners with access to reagents that are not only reliable but also engineered to meet rigorous quality standards. Allow us to support your research and development efforts with solutions tailored to your unique needs in today's competitive market.

Why Consider Mammalian Expression Your End-to-End Solution Products

Product	Expression System	Yield (mg/L)	Purity (%)	Applications
Monoclonal Antibody	HEK293	200	95	Therapeutics, Diagnostics
Recombinant Protein	CHO Cells	150	98	Research, Bioproduction
Fusion Protein	Mammalian Cells	120	90	Therapeutics, Laboratory Research
Enzyme	NS0 Cells	160	97	Industrial, Clinical
Vaccine Antigen	SFD Cells	300	99	Vaccination, Immunology

Mammalian Expression Systems: Efficiency Comparison Across Different Applications

The choice of expression system is critical for the successful development of various biopharmaceutical products. This chart illustrates the average time to market for different applications of mammalian expression systems, revealing how efficiently these systems can facilitate bioprocessing. The data shows that antibodies, which are complex proteins often produced for therapeutic purposes, can typically be brought to market within 8 months. Conversely, therapeutic proteins generally take around 12 months, indicating the intricacies involved in their production. Vaccines, vital in public health, show slightly longer timelines at 14 months due to their robust testing requirements. Enzymes can be produced and marketed in approximately 10 months, while hormones reflect the fastest timeline, taking just around 5 months. Understanding these timelines helps stakeholders in biopharmaceutical development make informed decisions regarding which expression system to utilize for specific products, optimizing efficiency and reducing time and costs in research and production phases.